Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biological markers in psychiatry.

M J Hoes

    Acta Psychiatrica Belgica
    |May 1, 1986
    PubMed
    Summary

    Biological markers for psychiatric disorders like depression and schizophrenia do not meet proposed criteria. Most current markers indicate general strain and stress, not specific disease processes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Recent antipsychotics in the treatment of psychoses.

    Acta neuropsychiatrica·2016
    Same author

    Biennal Conference of the German Research Society on Addictions, 27-30 March 1996.

    Addiction biology·2016
    Same author

    Improvement in alcoholics measured using the General Health Questionnaire.

    Alcohol and alcoholism (Oxford, Oxfordshire)·1998
    Same author

    [The method of Montignac: scientific foundation debatable].

    Nederlands tijdschrift voor geneeskunde·1998
    Same author

    Recent developments in the management of psychosis.

    Pharmacy world & science : PWS·1998
    Same author

    First report of mirtazapine overdose.

    International clinical psychopharmacology·1996

    Area of Science:

    • Psychiatry
    • Neuroscience
    • Biomarker Research

    Background:

    • Biological markers are crucial for understanding psychiatric disorders.
    • Existing literature lacks validated biomarkers for specific conditions like depression, schizophrenia, alcoholism, and anxiety.
    • Current markers often reflect general physiological responses rather than disease-specific mechanisms.

    Purpose of the Study:

    • To define criteria for biological markers in psychiatry.
    • To propose criteria for assigning biomarkers to disorder pathophysiology, pathogenesis, or etiology.
    • To evaluate existing biological markers against these proposed criteria.

    Main Methods:

    • Literature review of biological markers for major psychiatric disorders.
    • Development and application of proposed criteria for biomarker validation.
    • Analysis of the specificity and relevance of identified markers.

    Main Results:

    • No currently described biological markers for depression, schizophrenia, alcoholism, or anxiety meet the proposed stringent criteria.
    • Most investigated markers are better indicators of non-specific strain and stress.
    • Free-floating anxiety is identified as a key clinical indicator of strain.

    Conclusions:

    • There is a significant gap in validated biological markers for specific psychiatric disorders.
    • Current biomarkers primarily reflect general stress responses, limiting their diagnostic and etiological utility.
    • Further research is needed to develop specific and validated biomarkers for psychiatric conditions.

    Related Experiment Videos